Abstract
Most members of the TransMEMbrane protein 16 (TMEM16) family are Ca2+-regulated scramblases that facilitate the bidirectional movement of phospholipids across membranes necessary for diverse physiological processes. The nhTMEM16 scramblase (from the fungus Nectria hematococca) is a homodimer with a large cytoplasmic region and a hydrophilic, membrane-exposed groove in each monomer. The groove provides the transbilayer conduit for lipids, but the mechanism by which Ca2+ regulates it is not clear. Because fusion of large protein tags at either the N or C terminus abolishes nhTMEM16 activity, we hypothesized that its cytoplasmic portion containing both termini may regulate lipid translocation via a Ca2+-dependent conformational change. To test this hypothesis, here we used fluorescence methods to map key distances within the nhTMEM16 homodimer and between its termini and the membrane. To this end, we developed functional nhTMEM16 variants bearing an acyl carrier protein (ACP) tag at one or both of the termini. These constructs were fluorescently labeled by ACP synthase–mediated insertion of CoA-conjugated fluorophores and reconstituted into vesicles containing fluorescent lipids to obtain the distance of closest approach between the labeled tag and the membrane via FRET. Fluorescence lifetime measurements with phasor analysis were used to determine the distance between the N and C termini of partnering monomers in the nhTMEM16 homodimer. We now report that the measured distances do not vary significantly between Ca2+-replete and EGTA-treated samples, indicating that whereas the cytoplasmic portion of the protein is important for function, it does not appear to regulate scramblase activity via a detectable conformational change.
Keywords: fluorescence resonance energy transfer (FRET), liposome, ion channel, glycerophospholipid, membrane reconstitution, calcium, ACP tag, dithionite, fluorescence lifetime imaging (FLIM), MCP tag, scramblase
Introduction
Most members of the TMEM16 protein family are Ca2+-regulated phospholipid scramblases (1–3) that facilitate the bidirectional movement of phospholipids across membranes. TMEM16F, the first member of the family to be recognized as a scramblase, is responsible for the exposure of phosphatidylserine on the surface of activated blood platelets, a key step in blood coagulation (4, 5). Explicit demonstration of the scramblase activity of TMEM16 proteins was achieved when the fungal homologs from Aspergillus fumigatus (afTMEM16) (6) and Nectria haematococca (nhTMEM16) (7) were purified and reconstituted into large unilamellar vesicles and shown to be able to scramble a variety of fluorescently-tagged phospholipids at rates in excess of 10,000 lipids/s in the presence of Ca2+. Scrambling rates were ∼100-fold lower in the absence of Ca2+. Both proteins could also transport Cl− ions in a Ca2+-dependent manner (6, 8).
The crystal structure of Ca2+-bound nhTMEM16 revealed it to be a homodimer (Fig. 1A) (7) with a large cytoplasmic region and a hydrophilic, membrane-exposed groove in each monomer located distal to the dimer interface. The groove appears to provide the transbilayer pathway for lipids that was anticipated over a decade ago by the credit card model of lipid scrambling (9). In this model, the headgroups of transiting phospholipids populate the groove, whereas their acyl chains remain associated with the hydrophobic core of the membrane (2, 9, 10). Recent studies identified residues in the groove that are important for scrambling (11–13).
Figure 1.
Possible mechanism of Ca2+ activation of nhTMEM16 and structures of nhTMEM16 variants used in this study. A, crystal structure of the nhTMEM16 dimer (Protein Data Bank code 4WIS) in ribbon representation; the individual monomers are colored in green and light blue. The cytoplasmic regions are intertwined such that the C terminus of one monomer is positioned near the N terminus of the other. Ca2+ ions are shown as gold spheres, and the lines represent the membrane boundary, labeled to indicate the cytoplasmic (cyto) and exoplasmic (exo) faces. B, hypothetical mechanism of Ca2+-mediated activation of a TMEM16 scramblase. The cytoplasmic region of each monomer blocks the lipid translocation pathway in the inactive state. On binding of Ca2+ ions, a conformational switch causes these regions to swing away, thereby exposing the lipid pathway. This model of Ca2+ activation is based on the observation that GFP tagging of afTMEM16 and nhTMEM16 at the N or C terminus (both termini are located in the cytoplasmic portion (A)) blocks their scramblase activity. C, schematic illustration of ACP- and MCP-tagged nhTMEM16 constructs. All nhTMEM16 constructs were generated with an N-terminal module consisting of a His10 tag (cyan), followed by EGFP (green), and a 3C protease cleavage site (yellow). This module was removed by 3C protease treatment after initial protein purification to yield ACP–TMEM16, TMEM16–ACP, and MCP–TMEM16–ACP.
Despite these advances in understanding how TMEM16 scramblases facilitate phospholipid movement, the mechanism by which Ca2+ regulates their scrambling activity is less clear. It seems likely that Ca2+ binding produces a change in protein conformation and/or alters the electrostatic properties of the groove to enable scrambling (14). Interestingly, previous work pointed to the functional importance of the cytoplasmic portion of the protein. Thus, both the scramblase and ion channel activities of afTMEM16 and nhTMEM16 are eliminated when the cytoplasmic portion of the proteins is modified by attachment of a green fluorescent protein (GFP) tag to either the N or C terminus (8). We therefore considered the possibility that the cytoplasmic portion of the protein may play a role in regulating scramblase activity by blocking the lipid pathway in the inactive state and swinging out of the way in the Ca2+-bound active state to enable lipid passage (Fig. 1B).
To test this model, we reconstituted nhTMEM16 into large unilamellar vesicles and used Förster resonance energy transfer (FRET) to measure the distance of closest approach between a donor fluorophore situated at the N or C terminus of the protein and fluorescent lipid acceptors in the plane of the membrane. We also measured the distance between the N terminus of one monomer and the C terminus of its partner within the nhTMEM16 homodimer. As GFP tagging eliminates scrambling activity (8), and site-specific cysteine labeling is currently impractical, we developed a strategy for fluorescently labeling the protein while retaining functionality. A similar labeling strategy was used previously to study ligand-induced conformational changes of the epidermal growth factor receptor relative to the membrane (15). Thus, we generated fusion proteins in which small (∼8 kDa) acyl carrier protein (ACP)2 tags and mutant ACP (MCP) tags (16) were appended to the N and/or C terminus of nhTMEM16 (Fig. 1C). We found that the resulting fusion proteins retained their scramblase and channel functions and could be enzymatically labeled with high efficiency using fluorescent coenzyme A (CoA) derivatives. Using these novel fluorescent proteins, we now report that nhTMEM16 reconstitutes into vesicles asymmetrically, such that most molecules are oriented with their cytoplasmic portion in the extravesicular space. Steady-state and lifetime FRET-based structural mapping experiments reveal that the N and C termini of the protein appear to be locked relative to each other, and also with respect to the membrane, during Ca2+-mediated activation.
Results and discussion
ACP-tagged nhTMEM16
The gating model shown in Fig. 1B posits a Ca2+-induced conformational change in the cytoplasmic portion of the protein. To test this model, we set out to use FRET to determine whether the distance between the membrane surface and the cytoplasmically disposed N or C terminus of the protein is affected by Ca2+. Because GFP tagging inactivates both afTMEM16 and nhTMEM16, whereas attachment of a small 48-amino acid sequence (tandem tag consisting of Myc (10 amino acids) followed by a streptavidin-binding peptide (38 amino acids)) to the C terminus of nhTMEM16 does not (8), we considered using the ACP tag for fluorescence labeling (16). ACP is a 77-amino acid tag that can be readily labeled by ACP synthase-mediated transfer of a fluorophore from fluorescent CoA derivatives. We engineered the constructs shown in Fig. 1C, which after expression in Saccharomyces cerevisiae, purification by immobilized metal affinity chromatography, cleavage of the N-terminal His10-EGFP module, and gel filtration yielded well-behaved nhTMEM16 proteins with an N- or C-terminal ACP tag in similar yield as the nontagged protein (∼1 mg/liter of culture, prior to cleavage of the His10-EGFP module) (Fig. S1). We also generated a doubly-tagged protein (MCP–TMEM16–ACP) that will be discussed later.
ACP-tagged nhTMEM16 proteins are functional
We tested the purified ACP-tagged proteins for scramblase and ion channel activity. Scramblase activity was measured using a well-established fluorescence-based assay (Fig. 2A) (6, 17–19). Briefly, large unilamellar vesicles are reconstituted with TMEM16 and fluorescent nitrobenzoxadiazole-conjugated phosphatidylethanolamine (NBD)-PE. NBD-PE is irreversibly converted to nonfluorescent aminobenzoxadiazole-PE by dithionite, a dianionic reductant (6, 18, 20). Because dithionite does not enter the lumen of protein-free liposomes or TMEM16–proteoliposomes on the time scale of our experiments (6), it modifies only those NBD-PE molecules that are present in the outer leaflet. Thus, in protein-free liposomes, ∼50% of the fluorescence is predicted to be lost on adding dithionite, corresponding to bleaching of the outer-leaflet pool of NBD-PE. In the presence of a functional TMEM16 scramblase, dithionite is predicted to eliminate all fluorescence as NBD-PE molecules from the inner leaflet are scrambled to the outer leaflet. As shown previously (6–8), functional TMEM16 scramblases translocate NBD-PE rapidly in the presence of Ca2+ so that the chemical reduction reaction becomes rate-limiting. However, in the absence of Ca2+, scrambling is much slower, and the time course of fluorescence reduction is best described by a double-exponential function with the slow phase corresponding to the rate of scrambling (8).
Figure 2.
ACP–TMEM16 and TMEM16–ACP have both lipid scramblase and ion channel activity. A, schematic illustration of the phospholipid scramblase assay. See text for details. B, representative traces corresponding to scramblase activity assays for TMEM16, ACP–TMEM16, and TMEM16–ACP. Fluorescence was recorded with a frequency of 1 Hz using λex = 470 nm and λem = 530 nm. Arrowhead indicates dithionite addition. Traces correspond to protein-free vesicles (blue) and TMEM16 vesicles in the absence (black) or presence (red) of Ca2+. C, scramblase activity of nhTMEM16 and ACP-tagged variants. Activity was calculated as described in Table 1. D, schematic illustration of the ion-channel activity assay. See text for details. E, representative traces corresponding to the ion-channel activity assay. Three sets of traces are shown, each corresponding to vesicles prepared with no protein, ACP–TMEM16, or TMEM16–ACP. Traces correspond to protein-free vesicles (blue) and TMEM16-containing vesicles in the absence (black) or presence (red) of Ca2+. Arrowheads indicate addition of n-octyl-β-d-glucopyranoside to discharge-trapped Cl−. F, trapped Cl− was normalized to the value obtained with protein-free liposome samples that were analyzed in parallel with TMEM16-containing proteoliposomes. Scatter plots show individual measurements along with the mean and S.D. (error bars). Measurements were made in the absence (black) or presence (red) of Ca2+. The data for each condition were obtained from at least two independent reconstitutions and six traces.
All three tagged proteins (Fig. 1C) scrambled NBD-PE in a Ca2+-dependent fashion, similar to the activity of the nontagged protein (Fig. 2, B and C, and Table 1). Fluorescence reduction in the presence of Ca2+ was well-described in all cases by a single exponential function as reported previously, indicating that the rate of scrambling cannot be distinguished from that of the chemical reduction reaction (Table 1). In contrast, two kinetic components could be distinguished in the absence of Ca2+, corresponding to the expected fast rate of chemical reduction (τ1 ∼20 s (Table 1)) and a slower scrambling rate (τ2 ∼200–400 s (Table 1)) in the absence of Ca2+. We note that scrambling in the absence of Ca2+ appeared to be about 2-fold slower for the C-terminally tagged TMEM–ACP and MCP–TMEM–ACP proteins compared with ACP–TMEM16 and nontagged protein, suggesting mild interference by the C-terminal ACP tag that was not observed for the Myc-SBP tandem tag reported previously (8). The reasons for this are not clear, and as the effect is relatively small, it seems unlikely that C-terminal ACP tagging would affect our structural mapping experiments. Despite reconstituting five TMEM16 dimers per vesicle on average, we never observed complete fluorescence reduction (Fig. 1B). The fluorescence level reached after dithionite reduction of TMEM16-containing vesicles in the presence of Ca2+ was 0.13 ± 0.024 (mean ± S.D., n = 24, including measurements of all TMEM16 constructs) indicating that a significant fraction of the vesicles, ∼26%, is not reconstituted with protein. This phenomenon is well-known in reconstitution experiments, and the underlying reasons are not fully understood (6, 8, 19–21).
Table 1.
Scramblase activity assay of nhTMEM16 constructs
NA indicates not applicable.
Construct | % Scramblase activitya |
τ1b |
τ2b |
n | ||
---|---|---|---|---|---|---|
+Ca2+ | +EGTA | +Ca2+ | +EGTA | +EGTA | ||
s | s | |||||
Protein-free | NA | NA | 16 ± 3 | NA | NA | 9 |
nhTMEM16 | 93 ± 3 | 37 ± 12 | 20 ± 3 | 20 ± 3 | 210 ± 70 | 6 |
ACP–TMEM16 | 91 ± 9 | 46 ± 8 | 24 ± 6 | 21 ± 2 | 230 ± 20 | 6 |
TMEM16–ACP | 95 ± 3 | 32 ± 2 | 18 ± 3 | 14 ± 3 | 390 ± 40 | 6 |
MCP–TMEM16–ACP | 94 ± 2 | 35 ± 6 | 18 ± 4 | 14 ± 3 | 365 ± 105 | 6 |
a % scramblase activity = 100 × (FTMEM16 (t = 100 s) − FPF (t = 100 s))/(FTMEM16 + Ca (t = 900 s) − FPF (t = 900 s)), where FPF (t = 100 s) and FTMEM16 (t = 100 s) represent the fluorescence of protein-free vesicles and TMEM16-containing vesicles, respectively, 100 s after dithionite addition. FPF (t = 900 s) and FTMEM16 + Ca (t = 900 s) represent the fluorescence of protein-free vesicles and TMEM16-containing vesicles, in the presence of Ca2+, 900 s after dithionite addition. Values of FTMEM16 + Ca (t = 900 s) − FPF (t = 900 s) ranged from 0.36 to 0.50, similar to previous reports.
b Time constants τ1 and τ2 were obtained from a double exponential fit of the fluorescence reduction traces obtained on adding dithionite (for example, Fig. 2B). For protein-free liposomes and TMEM16-containing liposomes in the presence of 0.5 mm Ca2+, the traces were well-represented by a single exponential decay, hence only τ1 is reported for these samples.
Ion channel activity was measured as described previously (Fig. 2D) (6, 8). Briefly, vesicles are reconstituted with TMEM16 in the presence of 300 mm KCl (±Ca2+). The extravesicular solution is rapidly replaced with 1 mm KCl (±Ca2+), 300 mm sodium glutamate by passage through a desalting column, and the Cl− content of the extravesicular solution is measured with a Cl− electrode. Trapped Cl− is discharged by disrupting the vesicle membrane with the detergent n-octyl-β-d-glucopyranoside. Because nhTMEM16 is a nonselective ion channel, vesicles containing functional protein are expected to lose their Cl− content (replaced with glutamate) during the desalting step, which takes ∼2 min to complete. In contrast, Cl− is expected to be trapped in protein-free vesicles or TMEM16-containing vesicles in the absence of Ca2+. The amount of trapped Cl− indicates the fraction of vesicles that do not contain a functional channel. Representative experimental traces (Fig. 2E) and calculated data (Fig. 2F) indicate that both ACP–TMEM16 and TMEM16–ACP have channel activity that is essentially identical to that of the nontagged protein. The presence of trapped Cl− in 24.9 ± 4.7% (mean ± S.D., n = 13, including measurements of all TMEM16 constructs) of the proteoliposome samples in Ca2+-replete conditions indicates that a significant fraction of vesicles is not reconstituted with protein, consistent with a similar observation from our scramblase data. We conclude that ACP tagging, unlike GFP tagging, does not interfere with the scramblase (Fig. 2, B and C) and channel (Fig. 2, E and F) activities of nhTMEM16.
Distance of closest approach between the ACP tag in nhTMEM16 variants and the plane of the membrane
We fluorescently labeled ACP–TMEM16 and TMEM16–ACP using CoA-488 and reconstituted the labeled proteins into liposomes containing up to 2.0 mol % of R18 lipids to carry out FRET measurements as schematically illustrated in Fig. 3A. The fluorophores themselves are not sensitive to Ca2+ or EGTA (see “Experimental procedures”). Fluorescence emission spectra (λex = 480 nm) of samples prepared in the presence of Ca2+ or EGTA revealed a progressive increase in the magnitude of R18 emission as a function of the amount of reconstituted R18 (Fig. 3, B and D). Although a portion of this signal may be due to sensitized emission resulting from FRET, we observed that R18 has significant absorbance at the wavelength chosen for donor excitation and that the majority of the observed increase in fluorescence as a function of R18 concentration results from direct excitation of R18 (Fig. S2). Therefore, we used the loss of donor fluorescence as a function of R18 concentration (Fig. 3, C and E) to measure FRET.
Figure 3.
FRET between fluorescently labeled ACP-tagged TMEM16 and R18 in the plane of the membrane. A, principle of the FRET measurement. The illustration shows ACP-tagged TMEM16 labeled with CoA-488 donor fluorophore reconstituted into a phospholipid bilayer containing octadecylrhodamine B (R18). FRET between the donor fluorophore and plane of membrane-localized acceptor fluorophores depends on acceptor density. B, fluorescence emission spectra (λex = 480 nm) of CoA-488-labeled ACP–TMEM16 reconstituted into unilamellar vesicles composed of three parts (3 POPE, 1 POPG), to one part 60% egg PC) with different concentrations of R18 (0–2 mol % as indicated). Spectra were collected in the presence (solid lines) and absence (dotted lines) of Ca2+. C, zoomed region of the spectrum shown in B, showing decrease in donor emission as a function of increasing R18 concentration. D, as for B except that TMEM–ACP was used. E, as for C except that TMEM–ACP was used.
We quantified donor fluorescence (value at 520 nm, Fig. 3, C and E) in the presence of acceptor (FDA) and also after dispersal of the acceptor by treating the vesicles with Triton X-100 (FD, donor fluorescence in the absence of acceptor). These data were corrected using an identically prepared liposome sample lacking fluorophores and used to compute the ratio of the quantum yield (Q) of the donor in the absence versus presence of the acceptor (QD/QDA). In parallel, the surface density of R18 molecules in the membrane was calculated by measuring bulk phospholipid with a colorimetric assay after hydrolysis to Pi and quantifying R18 spectroscopically. Representative plots of QD/QDA versus acceptor density are shown in Fig. 4. The slope of the plots is proportional to the inverse fourth power of the distance of closest approach (L) between the donor fluorophore on the protein and the plane of R18 acceptors in the membrane (see “Experimental procedures”) (22, 23). L values of ∼50 Å were obtained with both ACP–TMEM16 and TMEM16–ACP, in the presence or absence of Ca2+ (Fig. 4, Table 2), consistent with the estimated position of the cytoplasmic portion of the protein relative to the plane of the membrane (Fig. 1) (7). We note that this estimate includes approximations for small sections of the sequence at the N and C terminus that could not be resolved in the nhTMEM16 crystal structure (7) and for the fluorophore-modified ACP tag.
Figure 4.
Determination of the distance of closest approach (L) between the protein-bound donor fluorophore and the membrane-localized plane of acceptors. The distance of closest approach between the CoA-488–labeled ACP tag on TMEM16 and R18 acceptors in the plane of the membrane was calculated as described under “Experimental procedures.” The ratio QD/QDA of the quantum yield of donor alone (QD) and donor in the presence of acceptor (QDA) was plotted against the surface density of R18 acceptor for ACP–TMEM16 (A) and TMEM16–ACP (B). The plots were analyzed by linear regression, and the slopes obtained were used to calculate the distance of closest approach (L) using Equation 2 (see under “Experimental procedures”) with Ro = 57.55 Å for the 488 dye- R18 donor–acceptor pair. The data represent a single reconstitution experiment, with each value determined in duplicate. Error bars indicate mean ± range (for some points the range is contained within the size of the plotted symbol). Measurements were carried out in the presence of Ca2+ (red) or EGTA (black) as indicated. L values corresponding to the data sets are indicated. The results of additional FRET experiments are reported in Table 2.
Table 2.
Distance of closest approach (L) obtained by FRET measurements between donor labeled proteins and membrane-localized acceptors
TMEM16 donor | Membrane acceptor | R0 | Slope ± S.E.a |
L (Å)b |
||
---|---|---|---|---|---|---|
+Ca2+ | +EGTA | +Ca2+ | +EGTA | |||
Å | ||||||
488-TMEM16 | R18 | 57.5 | 7790 ± 660 | 9200 ± 720 | 52.0 ± 1.0 | 50.0 ± 1.0 |
7000 ± 500 | 12100 ± 440 | 53.0 ± 1.0 | 46.5 ± 0.5 | |||
488-TMEM16 | Rh-DHPE | 57 | 6620 ± 1600 | 8200 ± 700 | 53.0 ± 3.0 | 51.0 ± 1.0 |
6100 ± 1400 | 14600 ± 3700 | 54.0 ± 3.0 | 44.0 ± 3.0 | |||
TMEM16-488 | R18 | 57.5 | 10000 ± 670 | 7930 ± 340 | 48.5 ± 0.5 | 52.0 ± 0.5 |
7600 ± 485 | 4820 ± 200 | 52.0 ± 1.0 | 58.5 ± 0.7 |
a The slope was obtained by linear regression of QD/QDA versus acceptor density data (e.g. Fig. 4); S.E. = standard error of the fit.
b L was calculated from the slope by using Equation 2 (see “Experimental procedures”). Each row of L values indicates an independent experiment involving a unique protein preparation and a series of reconstituted proteoliposomes containing different amounts of acceptor lipid. Data are given as mean ± S.D. from replicate measurements of each reconstituted vesicle sample. Forster radius (Ro) for each donor–acceptor pair was determined by using Equation 3 (see “Experimental procedures”) with a value of Ф (quantum yield of donor-labeled protein) = 0.44. Fluorescence measurements were carried out using λem = 520 nm, and λex = 480 and 492 nm, respectively, for R18 and Rh-DHPE.
The plots shown in Fig. 4 suggest Ca2+-dependent changes in the position of the ACP tag relative to the membrane, with the N terminus moving further away from the bilayer in the presence of Ca2+, whereas the C terminus moves toward the bilayer. To verify these results, we repeated these experiments and also used a different membrane lipid Rh-DHPE as a fluorescent acceptor. We obtained multiple data sets that are summarized in Table 2. Although on average the N terminus appears to be 5 Å further from the membrane in the presence of Ca2+, the difference between the +Ca2+ and +EGTA measurements is not significant (p > 0.1). Likewise, we did not find a significant change in the position of the C-terminal tag relative to the membrane in the +Ca2+ and +EGTA conditions (Table 2).
FLIM–FRET measurements with doubly-tagged nhTMEM16
We next attempted to measure the distance between the N terminus of one monomer and the C terminus of its partner monomer in the TMEM16 heterodimer (the N and C termini of an individual monomer are too far apart for FRET-based detection) (Fig. 1A) as a function of Ca2+. We purified MCP–TMEM16–ACP (Fig. 1C and Fig. S1) and verified that it had scramblase activity (Table 1). We exploited the difference in specificity of ACP synthase and its Bacillus subtilis counterpart (SFP synthase) to label sequentially the ACP tag with 488 dye and the MCP tag with 547 dye as described under “Experimental procedures.” FLIM with phasor representation was then used to measure FRET efficiency. For each sample, donor alone (D) and donor with acceptor (D + A), a lifetime image of the solution was acquired as described under “Experimental procedures.” Our FLIM system uses a digital frequency domain acquisition card, with a 491-nm excitation laser at a base frequency of 20 MHz, and six harmonics to describe the frequency response to detect FRET (24, 25). Data were analyzed using ISS FLIM software by the phasor plot at 40 MHz and by the multifrequency lifetime fit analyses at 20–140 MHz.
In a phasor plot, the sine and cosine transform of the time decay is calculated from the phase and modulation value obtained at every pixel of the FLIM image. This then places each pixel in the homogeneous image at a specific location on the universal semi-circle phasor plot, indicating a single exponential decay, or within the semi-circle, indicating a multiexponential decay (24, 25). A graphical representation of the data for CoA-488–labeled MCP–TMEM16–ACP (D) and CoA-488/CoA-547–labeled MCP–TMEM16–ACP (D + A) samples is shown in Fig. 5, A and B. Pixels for the D + A sample appear along the straight-line trajectory between the donor lifetime of τD on the semi-circle and a short lifetime τDA2. The D + A sample pixels are shifted ∼15% away from the donor lifetime toward the ∼1-ns lifetime τDA2, indicating that ∼15% of the intensity is due to a short fluorescence lifetime of ∼1 ns (τDA2), consistent with FRET, whereas ∼85% of the light comes from the longer donor-only lifetime of ∼3.6 ns (τDA1). The presence or absence of Ca2+ had no effect on the fractional population displaying FRET.
Figure 5.
FLIM phasor plots and multi-frequency lifetime fits of a CoA547/CoA488 labeled MCP–TMEM16–ACP. Protein samples (200 μl, 50 nm in Buffer D containing 0.1 mg/ml BSA and either 0.5 mm Ca(NO3)2 or 2 mm EGTA) in a LabTek multiwell coverglass plate were used for image collection. Phasor plots from FLIM acquisition of a solution of MCP–TMEM16-488 (donor) and 547-TMEM16-488 (donor + acceptor) in the presence (A) and the absence of Ca2+ (B) were measured at 40 MHz frequency. The highlighted circles on the phasor plots represent the lifetime of the donor ∼3.8 ns (yellow, τD) and donor + acceptor (red), which consist of two fractions: the major fraction (corresponding to the population that does not undergo FRET) has a lifetime ∼3.6 ns (τDA1 ∼ τD), and the minor fraction (corresponding to the population undergoing FRET) has a lifetime ∼1.0 ns (τDA2). Donor multifrequency FLIM data were fit to a single exponential decay model in the presence (C) or absence (D) of Ca2+, whereas donor + acceptor data were fit to a double exponential decay model in the presence (E) or absence (F) of Ca2+. A summary of these and additional data are provided in Table 3.
Analysis of the phase and modulation data yielded lifetimes consistent with the phasor results. Data for the CoA-488–labeled MCP–TMEM16–ACP (D) fit well to a single exponential with a lifetime of ∼3.8 ns in the presence and absence of Ca2+ (τD, Fig. 5, C and D, and Table 3), whereas data for the CoA-488/CoA-547–labeled MCP–TMEM16–ACP (D + A) fit well to a double-exponential decay with a combination of two emitting species at 3.6 ns (τDA1) and 1.2 ns (τDA2) in the presence of Ca2+ (Fig. 5E and Table 3) and 3.6 ns (τDA1) and 1.0 ns (τDA2) in the absence of Ca2+ (Fig. 5F and Table 3). The fractional population of molecules undergoing FRET recovered from the fits of the frequency response curves was found to be near 30% in all cases. Because the lifetime of the second component is shorter due to FRET, this population contributes only 15% of the intensity, consistent with the position of the pixels in the phasor plots. The FRET efficiency deduced from the donor-only lifetime τD and the short lifetime observed in the donor + acceptor samples, τDA2, was 73%, calculated using Equation 7 (“Experimental procedures,” with τDA2 = 1.0 ns). The distance between the donor and the acceptor for this FRET fraction was estimated to be ∼55 Å, calculated using Equation 8 and an R0 value of 65 Å (see under “Experimental procedures”).
Table 3.
Fluorescence lifetime measurements of nhTMEM16 by multifrequency phase/modulation
NA indicates not applicable.
Sample | τD ± S.D.a |
τDA1 ± S.D.a |
τDA2 ± S.D.a |
n | |||
---|---|---|---|---|---|---|---|
+Ca2+ | +EGTA | +Ca2+ | +EGTA | +Ca2+ | +EGTA | ||
ns | ns | ns | |||||
Db | 3.81 ± 0.05 | 3.79 ± 0.06 | >NA | >NA | >NA | >NA | 3 |
DAb | >NA | >NA | 3.61 ± 0.11 (0.7 ± 0.03)c | 3.62 ± 0.10 (0.72 ± 0.02)c | 1.18 ± 0.52 (0.3 ± 0.03)c | 0.97 ± 0.31 (0.29 ± 0.02)c | 4 |
a Lifetimes of donor (τD) and donor with acceptor (τDA) were analyzed by multifrequency lifetime fitting. Donor-alone (τD) lifetimes were best fit with a single-exponential function, whereas the donor + acceptor samples were fit to a double-exponential decay with two fractions, τDA1 and τDA2 (τDA1 is the lifetime of molecules that do not undergo FRET and τDA2 is the lifetime of molecules that undergo FRET). S.D. = standard deviation from the fits of n individual measurements from two independent protein preparations.
b D = MCP-TMEM16-488 (donor-only construct); DA = 547-TMEM16-488 (donor + acceptor construct).
c The numbers in parentheses correspond to the fractional population of the lifetime component τDA1 or τDA2.
Based on the labeling efficiency (∼80%; see under “Experimental procedures”), the maximal population of MCP–TMEM16–ACP molecules that can undergo FRET is ∼60–65%. However, only 30% of all molecules, i.e. ∼50% of the doubly-labeled population, undergoes FRET. Fluorescence polarization measurements on the donor indicated that it was freely rotating, and hence, the relative orientation of donor and acceptor dipoles should not be a limiting factor for FRET efficiency. However, it is possible that we did not observe FRET for the full potential protein population because the protein undergoes conformational dynamics that are slow on the time scale of fluorescence, leading to a situation in which the donor and acceptor are not within the appropriate distance necessary for FRET for a significant proportion of the molecules in the ensemble. Another possibility is that there is an appreciable acceptor fluorophore population in the dark state, which is consistent with the small sensitized emission signal seen in steady-state fluorescence (data not shown). Either of these possibilities would have lowered the fraction of observed FRET donor fluorophore lifetimes (26).
TMEM16 reconstitutes asymmetrically into proteoliposomes
In the course of our experiments on lipid scrambling by the different TMEM16 constructs, we noticed that the Atto-488 dye is bleached by dithionite. We made use of this observation to determine the orientation of ACP-tagged TMEM16 proteins in proteoliposomes. We reconstituted CoA-488–labeled ACP–TMEM16 or TMEM16–ACP into liposomes and treated the vesicles with dithionite after determining their initial fluorescence. As shown in Fig. 6A, >80% of the fluorescence was lost on dithionite treatment; complete loss of fluorescence was subsequently observed on adding Triton X-100 to disrupt the vesicle membrane. As dithionite does not enter TMEM16-containing proteoliposomes (6), these results indicate that the majority of the TMEM16 dimers are reconstituted asymmetrically such that their N and C termini are accessible to the extravesicular space (Fig. 6B).
Figure 6.
Asymmetric reconstitution of TMEM16. A, CoA-488–labeled ACP-tagged nhTMEM16 was reconstituted into liposomes, and its fluorescence was monitored as a function of time in a fluorescence spectrometer (λex = 492 nm and λem = 520 nm). Dithionite was added as indicated, followed by addition of Triton X-100 to disrupt the vesicles. B, loss of ∼80% of fluorescence was observed for both CoA-488–labeled ACP–TMEM16 and TMEM16–ACP in A, indicating that at least 80% of the proteins are oriented in the vesicles as shown, with their cytoplasmic portion (N and C termini) facing the extravesicular space.
Conclusion
We tested the hypothesis that a conformational change in the cytoplasmic region of TMEM16 scramblases is involved in controlling access to the transbilayer groove that forms the likely lipid and ion translocation pathway. This hypothesis is rooted in previous observations that the attachment of GFP tags to the N or C terminus of the fungal scramblases afTMEM16 and nhTMEM16 abrogates their scramblase activity without impacting overall protein structure, including the ability to dimerize (8). Our FRET-based analyses reveal that the distance of closest approach between the ACP tag at the N or C terminus of nhTMEM16 and the membrane does not vary significantly between Ca2+-replete and EGTA-treated samples. Likewise, the distance between the N terminus of one monomer and the C terminus of its partner does not change detectably in the presence of Ca2+, although for most molecules this distance could not be estimated by FRET because the termini are either too far apart or a significant population of the acceptor is in the dark state as discussed above. Our data therefore suggest that Ca2+-mediated activation of TMEM16 scramblases does not appear to require major movement of the cytoplasmic portion of the protein. It remains possible that a more nuanced movement of the cytoplasmic part of the protein is sufficient to control the lipid and ion pathway and that we could not detect it within the limitations of our measurements and/or that the relative movements of the fluorophores are such that they do not result in FRET changes. There are also other explanations that would account for our results. For example, it is known that detergents can activate membrane transporters (27). Thus, it is possible that detergent solubilization (the first step in obtaining purified protein after expression in yeast) converts nhTMEM16 into a partially active conformation and that this conformation is preserved even after detergent removal and reconstitution. This is consistent with the ability of nhTMEM16 to scramble lipids at a low rate even in the absence of added Ca2+. Although Ca2+ addition is necessary for full activation, it may be that the most significant conformational changes have already occurred irreversibly during protein purification accounting for our inability to detect these further Ca2+-mediated changes by FRET.
Recent structures of TMEM16A obtained by cryo-EM (28–30) and molecular dynamics simulations of nhTMEM16 (11) shed some light on this issue. TMEM16A, the founding member of the TMEM16 family, functions as a Ca2+-activated Cl− channel but lacks scramblase activity (1). The cryo-EM structures of TMEM16A indicate that it is a homodimer, but, unlike nhTMEM16, its component monomers interact minimally and are not intertwined on the cytoplasmic side (Fig. 1A). The structures of Ca2+-bound and apo-TMEM16A (29, 30), both in detergent and after reconstitution into nanodiscs, suggest that it is activated when a transmembrane helix (TM6) that lines the pore twists toward the Ca2+-binding site, directly interacting with the bound Ca2+ ions while simultaneously exposing the cytoplasmic entryway to the pore. The structural conservation between the channel-only TMEM16A protein and the channel/scramblase nhTMEM16 protein suggests that the activation mechanism proposed for pore-opening in TMEM16A may also control opening of the groove in nhTMEM16 to enable its scrambling function. Molecular dynamics simulations of nhTMEM16 indicate specific conformational changes in TM4 during Ca2+ activation (11). Because both structural and in silico studies suggest that Ca2+ activation may require conformational changes in TM domains, we engineered variants of nhTMEM16 in which a mini-ACP tag sequence (GDSLSWLLRLLNG) was inserted in the cytoplasmic loop between TM6 and TM7, bracketed by different spacer sequences. Our aim was to tag the apparently mobile end of TM6 with a fluorophore in order detect the changes in conformation that were suggested by the cryo-EM structures of the TMEM16A channel. However, these experiments were not successful as the expressed proteins could only be recovered as aggregates. The resolution of this issue will require the introduction of site-specific reagents, a goal for future work.
Finally, we note that our study introduces new tools for the study of TMEM16 scramblases. Thus, we report the first functional, fluorescently tagged variants of this class of scramblase proteins. We have already used these novel reagents in establishing the asymmetric reconstitution of TMEM16 (Fig. 6), a result that will be important in understanding macroscopic rate constants obtained from scramblase activity data.
Experimental procedures
Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) (POPG), egg l-α-phosphatidylcholine (60% purity, egg PC), and 1-myristoyl-2-[6-[(7-nitro-2–1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-glycero-3-phosphoethanolamine (NBD-PE) were obtained from Avanti Polar Lipids. n-Dodecyl-β-d-maltopyranoside (DDM) was from Anatrace; n-octyl-β-d-glucopyranoside was from Affymetrix; BioBeads SM2 adsorbent was from Bio-Rad; and ACP synthase, SFP synthase, CoA-488, and CoA-547 (based on Atto-488 (ATTO-TEC) and DY-547 (Dyomics), respectively) were from New England Biolabs. Octadecylrhodamine B chloride (R18) and Rh-DHPE were from ThermoFisher Scientific and Setareh Biotech, respectively. All other chemicals were from Sigma.
Buffers
The following buffers were used: Buffer A (50 mm HEPES, pH 7.6, 150 mm NaCl, 0.5 mm CaCl2, EDTA-free protease inhibitor mixture (Roche Applied Science, 1 tablet per 50 ml of buffer)); Buffer B (10 mm HEPES, pH 7.6, 150 mm NaCl, 5% (w/v) glycerol, 0.025% (w/v) DDM, 5 mm CaCl2); Buffer C (5 mm HEPES, pH 7.6, 150 mm NaCl, 0.025% (w/v) DDM, and 3 mm CaCl2); Buffer D (20 mm HEPES, pH 7.4, 300 mm KCl); and Buffer E (1 mm KCl, 300 mm sodium glutamate, 20 mm HEPES, pH 7.4).
nhTMEM16 constructs
Unique EcoRI and BamHI restriction sites were introduced at the 5′ and 3′ ends of the open reading frame in a construct encoding His10–EGFP–nhTMEM16. The ACP-tag sequence, generated by EcoRI/BamHI restriction digestion of the pACP-tag(m)-2 vector (New England Biolabs) was ligated to the nhTMEM16 sequence to generate constructs encoding His10–EGFP–ACP–TMEM16 and His10–EGFP–TMEM16–ACP. The double-tagged construct (MCP–TMEM16–ACP) was generated in two stages. The ACP tag was converted to MCP by introducing mutations into the pACP-tag(m)-2 plasmid corresponding to D36T and D39G, and after sequence verification, the MCP-encoding fragment was recovered by PCR and inserted at the 5′ end of the TMEM16–ACP gene by using the Gibson assembly cloning kit (New England Biolabs) according to the manufacturer's protocol.
Expression and purification of nhTMEM16 constructs
Protein expression and purification were carried out as described previously, using S. cerevisiae FGY217 (MATα ura3-52 lys2Δ201 pep4Δ) cells transformed with a modified pYES2/CT vector containing the gene of interest and a URA3 marker for selection of transformants (7, 8). Briefly, cells were grown to A600 ∼0.7–0.8 at 30 °C, before inducing expression of the TMEM16 construct with 2% (w/v) galactose at 25 °C and harvesting after 40 h. Cells were resuspended in Buffer A (supplemented with DNase I and 1 mm MgCl2) and disrupted using an Emulsiflex-C3 homogenizer at 25,000 p.s.i. After low-speed centrifugation to remove unbroken cells, membranes were pelleted by ultracentrifugation at 40,000 rpm (1.5 h, 4 °C) in a 45 Ti rotor (Beckman). Membranes were homogenized in Buffer A and solubilized in 1% (w/v) DDM at 4 °C for 1.5 h. Insoluble material was removed by centrifugation at 40,000 rpm for 0.5 h with 45 Ti rotor. The supernatant was incubated with 1 ml of nickel-nitrilotriacetic acid resin in the presence of 15 mm imidazole at 4 °C for 1.5 h. The resin was washed with 10 ml of Buffer B containing 50 mm imidazole. The protein was eluted with Buffer B modified to contain 400 mm imidazole.
The His10-EGFP tag was cleaved off by treating the purified protein with human rhinovirus 3C protease (overnight incubation, 4 °C, protein/protease mass ratio 1:1). After protease cleavage, the TMEM16 construct was purified by size-exclusion chromatography on a Superdex-200 gel-filtration column run in Buffer C.
The purified protein was taken for fluorescence labeling with CoA-488. The reaction was carried out at room temperature for 2 h using a molar ratio of TMEM16/CoA-488/SFP-synthase = 1:2:0.2 with 10 mm MgCl2. The labeled protein was re-purified by Superdex-200 gel–filtration chromatography using Buffer C. The degree of labeling was calculated from the absorbance spectrum of the labeled protein as ((Adye/ϵdye)/(Aprotein/ϵprotein)) × 100, where ϵdye = 73,000 m−1·cm−1 for CoA-488 at 495 nm, ϵprotein = 129,000 m−1·cm−1 at 280 nm calculated from the protein sequence using the ExPASy-ProtParam tool (https://web.expasy.org/protparam/), and A = absorbance at 280 and 495 nm, for protein and dye, respectively. Labeling efficiency (mean ± S.D.) was 79 ± 16% (n = 8) and 75 ± 12% (n = 2) for ACP–TMEM16 and TMEM16–ACP, respectively.
Proteoliposomes
Fluorescently labeled nhTMEM16 variants were reconstituted into proteoliposomes as described previously (6, 8, 31). Briefly, lipid stock solutions were mixed to obtain 20 mg of lipids (∼27 μmol) in a molar ratio of three parts (3 POPE, 1 POPG) to one part 60% egg PC and evaporated to dryness under a gentle stream of nitrogen. Fluorescent lipids were included in the lipid mixture before evaporating the solvent: C6-NBD-PE (0.5 mol %) was included in samples being prepared for scramblase assays, and R18 or Rh-DHPE (0.5–2.0 mol %) was included for FRET experiments. The obtained lipid film was hydrated with 1 ml of Buffer D, supplemented with 35 mm CHAPS, at room temperature for 30 min. The resulting lipid suspension was sonicated in a bath sonicator until it appeared clear, before adding protein (5 mg of protein per 1 mg of lipid mixture). After 30 min of incubation at room temperature, detergent was removed by stepwise addition of Bio-Beads SM-2 adsorbent (160 mg of Bio-Beads per ml, in four exchanges at 4 °C). Liposomes were subjected to three freeze–thaw cycles before being extruded 21 times through a 400-nm membrane filter (using a mini-extruder (Avanti Polar Lipids)) in the presence of 0.5 mm Ca(NO3)2 or 2 mm EGTA immediately prior to being taken for scramblase or flux assays, or for FRET measurements. Dynamic light scattering measurements (Zetasizer Nano-S, Malvern Instruments) indicated that the reconstituted proteoliposomes had an average diameter of ∼345 nm.
Scramblase assay
Scramblase activity was measured as described previously (6, 8). Briefly, 20 μl of extruded C6–NBD–PE-containing liposomes were diluted into 2 ml of Buffer D (with 50 mm, instead of 20 mm HEPES, pH 7.4) in the presence of 0.5 mm Ca(NO3)2 or 2 mm EGTA in a stirred cuvette at room temperature. Fluorescence (λex = 470 nm and λem = 530 nm) was monitored in a fluorescence spectrometer (Photon Technology International, HORIBA Scientific) at a frequency of 1 Hz as a function of time. After obtaining a stable initial fluorescence signal, 40 μl of freshly prepared sodium dithionite in 0.5 m Tris-HCl, pH 10 (20 mm final concentration), was added, and the resulting time-dependent fluorescence loss was monitored for 900 s.
Flux assay
Flux assays to measure channel activity were done as described previously (6, 8). Briefly, 100 μl of extruded liposomes were passed through a Superdex G-50 desalting column equilibrated in Buffer E in the presence of 0.5 mm Ca(NO3)2 or 2 mm EGTA. The flow-through was diluted into 2 ml of Buffer E, and Cl− content was measured using an AgCl electrode. The total Cl− content of the liposomes was determined by disrupting the liposomes with 40 μl of 1.5 m n-octyl-β-d-glucopyranoside. The change in Cl− content was normalized to the value obtained for protein-free liposomes in the presence of 0.5 mm Ca(NO3)2 prepared from the same batch of lipids.
Steady-state fluorescence measurements
Measurements were performed on continuously stirred samples at room temperature, using a Photon Technology International fluorescence spectrometer. Freshly extruded R18- or Rh-DHPE–containing proteoliposomes (5 μl) were diluted to 2 ml in Buffer D in the presence of 0.5 mm Ca(NO3)2 or 2 mm EGTA. Emission spectra were recorded by exciting the donor at λex = 480 nm for experiments with R18, and λex = 492 nm for Rh-DHPE. Spectra were corrected for light scattering by subtracting the signal from unlabeled liposomes lacking donor and acceptor fluorophores.
After measurement of donor emission (FDA, fluorescence of donor in the presence of acceptor), Triton X-100 (final concentration 0.1% (w/v)) was added to solubilize the vesicles and disperse the acceptors. The fluorescence of the Triton X-100–treated sample, FD, was considered to represent the fluorescence of donor in the absence of acceptor. Values of FD and FDA were corrected by subtracting the signal, FU, from identically treated unlabeled liposomes.
We determined that the fluorophores were not themselves sensitive to the presence of Ca2+ or EGTA by measuring the fluorescence of Triton X-100–solubilized vesicles containing either CoA-488–labeled, ACP-tagged TMEM16, or R18 in the presence and absence of Ca2+ (for the 488 fluorophore, we used λex = 480 nm and λem = 520 nm; for R18, we used λex = 560 nm and λem = 585 nm). The ratio of fluorescence in the presence versus absence of Ca2+ was 0.99 ± 0.15 (mean ± S.D., n = 8, four independent reconstitutions) and 1.00 ± 0.10 (mean ± S.D., n = 10, two independent reconstitutions), for the 488 fluorophore and R18, respectively.
The ratio of the quantum yield of the donor in the absence (QD) or presence (QDA) of acceptor was calculated from the fluorescence data according to Equation 1.
(Eq. 1) |
Distance of closest approach (L)
L was calculated from QD/QDA and the surface density of the acceptor in the membrane. The surface density of acceptor was determined by the following: (i) quantifying bulk lipids by measuring Pi released after acid hydrolysis (32); (ii) quantifying the acceptor by measuring absorbance at 560 nm using a molar extinction coefficient of 100,000 m−1 cm−1 for R18 and 119,400 m−1 cm−1 for Rh-DHPE; and (iii) assuming that a phospholipid molecule has a cross-sectional area of 70 Å2 and that the acceptors are distributed uniformly and randomly on the surface of the bilayer (33). The slope of a plot of QD/QDA versus the surface density of acceptors (Å−2) was used to calculate L according to Equation 2 (22, 23, 34, 35).
(Eq. 2) |
The Förster distance (R0, in Å units) for donor and acceptor pairs was calculated from the degree of overlap between the donor emission spectrum and acceptor absorption spectrum using Equation 3 (36),
(Eq. 3) |
where the orientation factor κ2 = 0.67 (assuming random orientation of the donor and acceptor), the refractive index of the buffer was measured as η = 1.33, and the overlap integral J was calculated by using PhotochemCAD software (http://www.photochemcad.com/pages/chemcad/chem-home.html)3 (39). The relative quantum yield (ΦD) of CoA-488–labeled nhTMEM16 was determined to be 0.44. This number was obtained by comparison with a reference solution of fluorescein in 0.1 n NaOH (fluorescein has a quantum yield ΦF = 0.95) using Equation 4 (36),
(Eq. 4) |
where GD and GF are the gradients of plots of integrated fluorescence intensity versus absorbance for CoA-488–labeled TMEM16 and the fluorescein standard, respectively, and ηD and ηF are the refractive indices of the corresponding solutions.
Distance between the N terminus of one monomer and the C terminus of its partner by using FLIM–FRET measurements
Purified MCP–TMEM16–ACP was doubly labeled as follows. The ACP tag was labeled with CoA-488 using ACP synthase as described above. The labeled protein was purified by gel filtration, and a portion was incubated with CoA-547 in the presence of SFP synthase to label the MCP tag. The CoA-488–labeled protein (donor) and CoA-488/CoA-547 (donor + acceptor)–labeled protein samples were diluted in Buffer D. Protein concentrations were determined by measuring absorbance at 280, 488, and 550 nm for protein, 488-dye, and 547-dye, respectively. Labeling efficiency (determined as described above; for the 547-dye we used ϵdye = 150,000 m−1·cm−1 at 555 nm) was ∼80% for both MCP and ACP tags.
FLIM images were acquired on solutions of the donor only and donor + acceptor samples using digital frequency-domain fluorescence lifetime imaging on a FLIM/FFS laser-scanning microscope equipped with 488 nm ISS Albav5 at a base frequency of 20 MHz. A dichroic filter (530/43 nm) was used to collect the donor emission within a 50-μm pinhole onto a photomultiplier tube detector. FLIM data were collected using 60% of laser power and 100-μs pixel dwell time over 10 frames for CoA-488–labeled MCP–TMEM16–ACP (donor) and 60 frames CoA-488/CoA-547–labeled MCP–TMEM16–ACP (donor + acceptor) in a 20 × 20-μm image of 256 × 256 pixels. Each pixel is represented as a point in a phasor plot with S and G coordinates, i.e. a single exponential lifetime point is located on the semi-circle (37) defined by Equations 5 and 6.
(Eq. 5) |
(Eq. 6) |
FLIM was calibrated with 46 nm fluorescein in 50 mm Tris buffer at pH 8 (reference fluorescence lifetime of 4.04 ns) under similar conditions of protein samples for 10 frames. After the measurements of phase delays and modulation ratios of the emission of each image at a frequency of 40 MHz, the phasor position of all pixels was determined using Equations 5 and 6 (Fig. 5, A and B). The ratio of the donor lifetimes determined in the absence (τD) and in the presence of the acceptor (τDA) allows us to estimate the FRET efficiency (EFRET) by using Equation 7 (38).
(Eq. 7) |
Using E and R0 values, the distance between the donor and acceptor can be calculated by Equation 8 (31).
(Eq. 8) |
Orientation of TMEM16 in proteoliposomes
The 488 dye is susceptible to chemical reduction by dithionite, resulting in loss of fluorescence. ACP-tagged nhTMEM16 constructs labeled via CoA-488 were reconstituted into vesicles consisting of three parts (3 POPE, 1 POPG) to 1 part 60% egg PC as described above. The reconstituted sample (20 μl, diluted to 2 ml in Buffer D) was placed in a cuvette, and its fluorescence was monitored over time (λex = 492 nm and λem = 520 nm) in a fluorescence spectrometer. Dithionite (20 mm final concentration, from a 1 m stock solution freshly prepared in 0.5 m Tris-HCl, pH 10) was added to eliminate fluorescence of fluorophores accessible at the vesicle exterior. Triton X-100 (final concentration 0.1% (w/v)) was subsequently added to permeabilize the vesicles, enabling dithionite to reduce all dye molecules.
Author contributions
K. K. A., C. R., and A. K. M. conceptualization; K. K. A., C. R., and A. K. M. data curation; K. K. A., C. R., and A. K. M. formal analysis; K. K. A., S. D., C. R., and A. K. M. investigation; K. K. A., S. D., C. R., and A. K. M. methodology; K. K. A., C. R., and A. K. M. writing-original draft; K. K. A., S. D., C. R., and A. K. M. writing-review and editing; C. R. and A. K. M. supervision; A. K. M. resources; A. K. M. funding acquisition; A. K. M. project administration.
Supplementary Material
Acknowledgments
We thank David Holowka (Department of Chemistry and Chemical Biology, Cornell University) and Joshua Levitz (Department of Biochemistry, Weill Cornell Medical College) for helpful discussions; David Eliezer (Department of Biochemistry, Weill Cornell Medical College) for comments on the manuscript; Prof. Ching Tung (Department of Radiology, Weill Cornell Medicine) for use of a DLS instrument; Saulius Vainauskas and Chris Provost (New England Biolabs) for their assistance in obtaining ACP- and MCP-tag reagents; and Shintaro Katsu for stimulation.
This work was supported by National Institutes of Health Grant R01 GM106717 (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
This article contains Figs. S1–S2.
Please note that the JBC is not responsible for the long-term archiving and maintenance of this site or any other third party hosted site.
- ACP
- acyl carrier protein
- DDM
- n-dodecyl-β-d-maltopyranoside
- PC
- phosphatidylcholine
- FLIM
- Fluorescence Lifetime Imaging
- MCP
- mutant ACP
- R18
- octadecylrhodamine B
- POPE
- 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
- POPG
- 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)
- Rh-DHPE
- rhodamine B 1,2 dihexadecanoyl-sn-glycero-3-phosphoethanolamine
- NBD-PE
- nitrobenzoxadiazole-conjugated phosphatidylethanolamine
- EGFP
- enhanced GFP.
References
- 1. Whitlock J. M., and Hartzell H. C. (2017) Anoctamins/TMEM16 proteins: chloride channels flirting with lipids and extracellular vesicles. Annu. Rev. Physiol. 79, 119–143 10.1146/annurev-physiol-022516-034031 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Pomorski T. G., and Menon A. K. (2016) Lipid somersaults: uncovering the mechanisms of protein-mediated lipid flipping. Prog. Lipid Res. 64, 69–84 10.1016/j.plipres.2016.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Montigny C., Lyons J., Champeil P., Nissen P., and Lenoir G. (2016) On the molecular mechanism of flippase- and scramblase-mediated phospholipid transport. Biochim. Biophys. Acta 1861, 767–783 10.1016/j.bbalip.2015.12.020 [DOI] [PubMed] [Google Scholar]
- 4. Bevers E. M., and Williamson P. L. (2016) Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane. Physiol. Rev. 96, 605–645 10.1152/physrev.00020.2015 [DOI] [PubMed] [Google Scholar]
- 5. Suzuki J., Umeda M., Sims P. J., and Nagata S. (2010) Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468, 834–838 10.1038/nature09583 [DOI] [PubMed] [Google Scholar]
- 6. Malvezzi M., Chalat M., Janjusevic R., Picollo A., Terashima H., Menon A. K., and Accardi A. (2013) Ca2+-dependent phospholipid scrambling by a reconstituted TMEM16 ion channel. Nat. Commun. 4, 2367 10.1038/ncomms3367 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Brunner J. D., Lim N. K., Schenck S., Duerst A., and Dutzler R. (2014) X-ray structure of a calcium-activated TMEM16 lipid scramblase. Nature 516, 207–212 10.1038/nature13984 [DOI] [PubMed] [Google Scholar]
- 8. Lee B. C., Menon A. K., and Accardi A. (2016) The nhTMEM16 scramblase is also a nonselective ion channel. Biophys. J. 111, 1919–1924 10.1016/j.bpj.2016.09.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Pomorski T., and Menon A. K. (2006) Lipid flippases and their biological functions. Cell. Mol. Life Sci. 63, 2908–2921 10.1007/s00018-006-6167-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Kobayashi T., and Menon A. K. (2018) Transbilayer lipid asymmetry. Curr. Biol. 28, R386–R391 10.1016/j.cub.2018.01.007 [DOI] [PubMed] [Google Scholar]
- 11. Jiang T., Yu K., Hartzell H. C., and Tajkhorshid E. (2017) Lipids and ions traverse the membrane by the same physical pathway in the nhTMEM16 scramblase. Elife 6, e28671 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Gyobu S., Ishihara K., Suzuki J., Segawa K., and Nagata S. (2017) Characterization of the scrambling domain of the TMEM16 family. Proc. Natl. Acad. Sci. U.S.A. 114, 6274–6279 10.1073/pnas.1703391114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Bethel N. P., and Grabe M. (2016) Atomistic insight into lipid translocation by a TMEM16 scramblase. Proc. Natl. Acad. Sci. U.S.A. 113, 14049–14054 10.1073/pnas.1607574113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Brunner J. D., Schenck S., and Dutzler R. (2016) Structural basis for phospholipid scrambling in the TMEM16 family. Curr. Opin. Struct. Biol. 39, 61–70 10.1016/j.sbi.2016.05.020 [DOI] [PubMed] [Google Scholar]
- 15. Ziomkiewicz I., Loman A., Klement R., Fritsch C., Klymchenko A. S., Bunt G., Jovin T. M., and Arndt-Jovin D. J. (2013) Dynamic conformational transitions of the EGF receptor in living mammalian cells determined by FRET and fluorescence lifetime imaging microscopy. Cytometry A 83, 794–805 10.1002/cyto.a.22311 [DOI] [PubMed] [Google Scholar]
- 16. Johnsson N., George N., and Johnsson K. (2005) Protein chemistry on the surface of living cells. Chembiochem 6, 47–52 10.1002/cbic.200400290 [DOI] [PubMed] [Google Scholar]
- 17. Menon I., Huber T., Sanyal S., Banerjee S., Barré P., Canis S., Warren J. D., Hwa J., Sakmar T. P., and Menon A. K. (2011) Opsin is a phospholipid flippase. Curr. Biol. 21, 149–153 10.1016/j.cub.2010.12.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Goren M. A., Morizumi T., Menon I., Joseph J. S., Dittman J. S., Cherezov V., Stevens R. C., Ernst O. P., and Menon A. K. (2014) Constitutive phospholipid scramblase activity of a G protein-coupled receptor. Nat. Commun. 5, 5115 10.1038/ncomms6115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Ploier B., Caro L. N., Morizumi T., Pandey K., Pearring J. N., Goren M. A., Finnemann S. C., Graumann J., Arshavsky V. Y., Dittman J. S., Ernst O. P., and Menon A. K. (2016) Dimerization deficiency of enigmatic retinitis pigmentosa-linked rhodopsin mutants. Nat. Commun. 7, 12832 10.1038/ncomms12832 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Pandey K., Ploier B., Goren M. A., Levitz J., Khelashvili G., and Menon A. K. (2017) An engineered opsin monomer scrambles phospholipids. Sci. Rep. 7, 16741 10.1038/s41598-017-16842-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Lee S.-Y., Letts J. A., and MacKinnon R. (2009) Functional reconstitution of purified human Hv1 H+ channels. J. Mol. Biol. 387, 1055–1060 10.1016/j.jmb.2009.02.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Holowka D., and Baird B. (1983) Structural studies on the membrane-bound immunoglobulin E-receptor complex. 2. Mapping of distances between sites on ige and the membrane-surface. Biochemistry 22, 3475–3484 10.1021/bi00283a026 [DOI] [PubMed] [Google Scholar]
- 23. Baird B., and Holowka D. (1985) Structural mapping of Fc-receptor bound immunoglobulin-E- proximity to the membrane-surface of the antibody combining site and another site in the fab segments. Biochemistry 24, 6252–6259 10.1021/bi00343a032 [DOI] [PubMed] [Google Scholar]
- 24. Stringari C., Cinquin A., Cinquin O., Digman M. A., Donovan P. J., and Gratton E. (2011) Phasor approach to fluorescence lifetime microscopy distinguishes different metabolic states of germ cells in a live tissue. Proc. Natl. Acad. Sci. U.S.A. 108, 13582–13587 10.1073/pnas.1108161108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Digman M. A., Caiolfa V. R., Zamai M., and Gratton E. (2008) The phasor approach to fluorescence lifetime imaging analysis. Biophys. J. 94, L14–L16 10.1529/biophysj.107.120154 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Vogel S. S., Nguyen T. A., van der Meer B. W., and Blank P. S. (2012) The impact of heterogeneity and dark acceptor states on FRET: implications for using fluorescent protein donors and acceptors. PLoS ONE 7, e49593 10.1371/journal.pone.0049593 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Wielandt A. G., Pedersen J. T., Falhof J., Kemmer G. C., Lund A., Ekberg K., Fuglsang A. T., Pomorski T. G., Buch-Pedersen M. J., and Palmgren M. (2015) Specific activation of the plant P-type plasma membrane H+-ATPase by lysophospholipids depends on the autoinhibitory N- and C-terminal domains. J. Biol. Chem. 290, 16281–16291 10.1074/jbc.M114.617746 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Paulino C., Neldner Y., Lam A. K., Kalienkova V., Brunner J. D., Schenck S., and Dutzler R. (2017) Structural basis for anion conduction in the calcium-activated chloride channel TMEM16A. Elife 6, e26232 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Paulino C., Kalienkova V., Lam A. K. M., Neldner Y., and Dutzler R. (2017) Activation mechanism of the calcium-activated chloride channel TMEM16A revealed by cryo-EM. Nature 552, 421–425 10.1038/nature24652 [DOI] [PubMed] [Google Scholar]
- 30. Dang S., Feng S., Tien J., Peters C. J., Bulkley D., Lolicato M., Zhao J., Zuberbühler K., Ye W., Qi L., Chen T., Craik C. S., Jan Y. N., Minor D. L. Jr., Cheng Y., and Jan L. Y. (2017) Cryo-EM structures of the TMEM16A calcium-activated chloride channel. Nature 552, 426–429 10.1038/nature25024 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Saha J., Datta Roy A., Dey D., Chakraborty S., Bhattacharjee D., Paul P. K., and Hussain S. A. (2015) Investigation of fluorescence resonance energy transfer between fluorescein and rhodamine 6G. Spectrochim. Acta A Mol. Biomol. Spectrosc. 149, 143–149 10.1016/j.saa.2015.04.027 [DOI] [PubMed] [Google Scholar]
- 32. Rouser G., Fkeischer S., and Yamamoto A. (1970) Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5, 494–496 10.1007/BF02531316 [DOI] [PubMed] [Google Scholar]
- 33. Mimms L. T., Zampighi G., Nozaki Y., Tanford C., and Reynolds J. A. (1981) Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry 20, 833–840 10.1021/bi00507a028 [DOI] [PubMed] [Google Scholar]
- 34. Holowka D., and Baird B. (1983) Structural studies on the membrane-bound immunoglobulin E-receptor complex. 1. Characterization of large plasma membrane vesicles from rat basophilic leukemia cells and insertion of amphipathic fluorescent probes. Biochemistry 22, 3466–3474 10.1021/bi00283a025 [DOI] [PubMed] [Google Scholar]
- 35. Shaklai N., Yguerabide J., and Ranney H. M. (1977) Interaction of hemoglobin with red blood cell membranes as shown by a fluorescent chromophore. Biochemistry 16, 5585–5592 10.1021/bi00644a031 [DOI] [PubMed] [Google Scholar]
- 36. Lakowicz J. R. (2006) Principles of Fluorescence Spectroscopy, 3rd Ed., Springer, New York [Google Scholar]
- 37. Szmacinski H., Toshchakov V., and Lakowicz J. R. (2014) Application of phasor plot and autofluorescence correction for study of heterogeneous cell population. J. Biomed. Opt. 19, 046017 10.1117/1.JBO.19.4.046017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Day R. N. (2014) Measuring protein interactions using Forster resonance energy transfer and fluorescence lifetime imaging microscopy. Methods 66, 200–207 10.1016/j.ymeth.2013.06.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Dixon J. M., Taniguchi M., and Lindsey J. S. (2005) PhotochemCAD 2. A refined program with accompanying spectral databases for photochemical calculations. Photochem. Photobiol. 81, 212–213 10.1562/2004-11-06-TSN-361.1 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.